Epigenetic modulators as therapeutic targets in prostate cancer

Prostate cancer is one of the most common non-cutaneous malignancies among men worldwide. Epigenetic aberrations, including changes in DNA methylation patterns and/or histone modifications, are key drivers of prostate carcinogenesis. These epigenetic defects might be due to deregulated function and/...

ver descrição completa

Detalhes bibliográficos
Autor principal: Pinho dos Santos Graça, Maria Inês (author)
Outros Autores: Pereira-Silva, Eva (author), Henrique, Rui (author), Packham, Graham (author), Crabb, Simon J. (author), Jerónimo, Carmen (author)
Formato: article
Idioma:eng
Publicado em: 2017
Assuntos:
Prostate cancer
DNMTi
Histone modulators
Texto completo:http://hdl.handle.net/10400.22/9336
País:Portugal
Oai:oai:recipp.ipp.pt:10400.22/9336

Texto Completo

http://hdl.handle.net/10400.22/9336

Registros relacionados